Erivedge and Gallstones - a phase IV clinical study of FDA data

Summary:

Gallstones is reported as a side effect among people who take Erivedge (vismodegib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Celebrex, and have Basal cell carcinoma.

The phase IV clinical study analyzes which people have Gallstones when taking Erivedge. It is created by eHealthMe based on reports of 7,786 people who have side effects when taking Erivedge from the FDA, and is updated regularly.

What is Erivedge?

Erivedge has active ingredients of vismodegib. eHealthMe is studying from 7,787 Erivedge users. Check the latest studies of Erivedge.

What is Gallstones?

Gallstones (stone formation by bile component) is found to be associated with 1,816 drugs and 2,096 conditions by eHealthMe. Check the latest studies of Gallstones.

On Jul, 13, 2026

7,786 people reported to have side effects when taking Erivedge.
Among them, 13 people (0.17%) have Gallstones.

Among these 13 people:

How long have people been on Erivedge when they have Gallstones? *

What is the gender of people who have Gallstones when taking Erivedge? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Gallstones when taking Erivedge? *

What are other drugs people take besides Erivedge? *

What are other side effects people have besides Gallstones? *

Nausea (feeling of having an urge to vomit): 9 people, 69.23%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 69.23%
Hair Loss: 9 people, 69.23%
Fatigue (feeling of tiredness): 9 people, 69.23%
Muscle Spasms (muscle contraction): 9 people, 69.23%
Entropion (eyelid (usually the lower lid) folds inward): 8 people, 61.54%
Joint Dislocation (a joint position is changed from normal position): 8 people, 61.54%
Insomnia (sleeplessness): 8 people, 61.54%
Haemorrhage (bleeding): 8 people, 61.54%
Facial Pain: 8 people, 61.54%

What are the existing conditions these people have? *

Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 10 people, 76.92%
Pain: 8 people, 61.54%
Nausea (feeling of having an urge to vomit): 8 people, 61.54%
Neoplasm Malignant (cancer tumour): 2 people, 15.38%
Metastases To Lymph Nodes (cancer spreads to lymph node): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Erivedge and have Gallstones?

- Check whether Gallstones is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erivedge:

Erivedge (7,787 reports)

Gallstones treatments and more:

Gallstones (50,126 reports)

Browse all side effects of Erivedge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallstones:

Gallstones (1,816 drugs)

Browse all the conditions that are associated with Gallstones:

Gallstones (2,096 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vismodegib (the active ingredients of Erivedge) and Erivedge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.